Table 1. Patient characteristics (n=19).
| Characteristic | n (%) |
|---|---|
|
Sex | |
| Male | 9 (47) |
| Female |
10 (53) |
|
Age (years) | |
| Median (range) |
50 (22–70) |
|
Performance status | |
| 0 | 3 (16) |
| 1 | 12 (63) |
| 2 |
4 (21) |
|
ENSAT tumour stage | |
| IV |
19 (100) |
|
Site of tumours | |
| Adrenal gland+other viscera | 7 (37) |
| Adrenal gland+lymph nodes | 1 (5) |
| Lymph nodes only | 2 (11) |
| Other viscera only | 7 (37) |
| Other viscera+lymph nodes+adrenal gland | 2 (11) |
| Lung | 14 (74) |
| Liver |
8 (42) |
|
No. of disease sites | |
| 1 | 5 (26) |
| 2 | 5 (26) |
| >2 |
9 (47) |
|
Endocrine symptoms | |
| Cushing's syndrome | 9 (47) |
| No symptoms |
10 (53) |
|
Prior treatment | |
| Surgery | 19 (100) |
| Radiotherapy | 0 |
| Mitotanea | 5 (26) |
a
All patients treated with mitotane had progressive disease at the time of inclusion.